Refine by
Biopsy Tissue Articles & Analysis
15 news found
About Carcinotech Carcinotech is revolutionising cancer research by manufacturing 3D-printed micro-tumours using patient-derived biopsies, primary cells, immune cells, and cancer stem cells. Our advanced offering provides a platform for rapid, ethical, and accurate drug screening, pre-clinical, and personalised medicine testing. Carcinotech’s goal is to accelerate drug ...
ByCELLINK
DR CHENG BOON, ONCOLOGIST IN THE PRIVATE SECTOR AND THE NHS AS WELL AS ACTING AS ONCODNA UK MEDIAL DIRECTOR COMMENTED: “In my view, this is an important first step in a collaboration that will make it much easier for public and privately practising oncologists to access biopsy tissue and request ONCODEEP* for the purpose of routine next generation ...
Koios Medical, Inc has received 510(k) clearance from the U.S. Food and Drug Administration for Koios DS (Decision Support) Breast 2.0, a new version of its machine learning based platform that assists physicians in the classification and diagnosis of breast cancer. The software offers a proprietary alignment to BI-RADS® for any lesion analyzed and is available connected to PACS and/or ...
Northstar Response is a methylation-based, tissue-agnostic treatment response monitoring assay. Using our molecular counting technology, the assay provides absolute quantification of methylated circulating tumor DNA (ctDNA) burden. ...
Organoids are stem cell-derived mini-organs developed from any patient resection or biopsy tissue that can be grown in the laboratory, which can be applied like conventional cell lines in early drug discovery. ...
The new sheath, the company says, makes the system the “first and only” integrated biopsy device not requiring the use of additional instruments. "The FDA approval of our LUMINELLE Bx Sheath not only marks a major milestone for UVision360, but is also a game changer when it comes to the standard of care for tissue biopsy ...
Feeney’s expertise building sales and market access teams across specialty areas, including liquid biopsy, oncology, and women's health, will play a critical role in advancing the commercial strategy and development of 4D Path’s cancer diagnostic and precision oncology platform technology. ...
The test integrates genomic and epigenomic signatures to detect disease without the need for tumor tissue. (Abstract 168) Additionally, clinical utility data will demonstrate that the Guardant360® liquid biopsy test detects microsatellite instability-high (MSI-H) status in patients with advanced gastrointestinal cancers at a similar frequency to ...
The LUMINELLE DTx System is an endoscopic platform assisting both male/female procedures, bringing operating room capabilities affordably to physician offices so bladder and uterine tissue samples can be obtained easily with visualization. "The FDA approval of our LUMINELLE Bx Sheath not only marks a major milestone for UVision360 but is also a game changer when it comes to the ...
“Understanding a patient’s gene expression within atherosclerotic plaque may provide novel prognostic insights. This typically would require tissue biopsy or surgery, which is not feasible for most patients,” said Dr. ...
ByElucid
This review paper provides unique insight into liquid biopsies and the field of exosomes in the context of other liquid biopsies such as cfDNA and CTC analysis. ...
Coughed-up sputum and invasive biopsies that do not work well in critical patient cohorts and blood culture tests which take weeks to get results are limiting factors and can give many false negatives”. ...
CrossBay Medical, Inc., today announced that it has received clearance to commercialize its product, the Endometrial Tissue Sampler using CrossGlide™ technology, in Europe by obtaining its CE Mark. The use of this technology allows a novel way to obtain an office-based endometrial biopsy, a very common tissue-sampling procedure performed in ...
AVRA will utilize oVio’s imaging technology to “robotize” a wide range of medical procedures that are currently being performed by human hands, such as: biopsies, tissue targeting, neurological repair, internal organ procedures and more. ...
The University of Arizona has licensed the design for a next-generation needle biopsy instrument that utilizes electrosurgery and electrocautery to safely increase tissue sample volumes in minimally invasive biopsy procedures. ...